|
Volumn 104, Issue 1, 2009, Pages 257-258
|
Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
CYTOCHROME P450 3A4;
GLUCURONOSYLTRANSFERASE 1A9;
PROTHROMBIN;
SORAFENIB;
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
ACUTE HEPATITIS;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BILIRUBIN BLOOD LEVEL;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG WITHDRAWAL;
HALF LIFE TIME;
HEPATITIS C VIRUS;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER DYSFUNCTION;
LIVER FUNCTION;
LIVER INJURY;
LIVER TOXICITY;
MALE;
OBSTRUCTIVE JAUNDICE;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
TUMOR GROWTH;
ULTRASOUND;
ACUTE DISEASE;
DRUG EFFECT;
HEPATITIS C;
LIVER;
LIVER TUMOR;
TOXIC HEPATITIS;
VIROLOGY;
ACUTE DISEASE;
AGED;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, HEPATOCELLULAR;
HEPATITIS C;
HEPATITIS, TOXIC;
HUMANS;
LIVER;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
MALE;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
|
EID: 60749098916
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2008.41 Document Type: Letter |
Times cited : (23)
|
References (5)
|